Cost-effectiveness of sustained-release morphine for refractory breathlessness in COPD: a randomized clinical trial
Chronic breathlessness is a frequent symptom in advanced Chronic Obstructive Pulmonary Disease (COPD) and has major impact on quality of life, daily activities and healthcare utilization. Morphine is used as palliative treatment of chronic breathlessness. The aim is to analyze cost-effectiveness of regular, low-dose morphine in patients with advanced COPD from a healthcare and societal perspective.
Source: Respiratory Medicine - Category: Respiratory Medicine Authors: Cornelia A. Verberkt, Marieke H.J. van den Beuken-van Everdingen, Carmen D. Dirksen, Jos M.G.A. Schols, Emiel F.M. Wouters, Daisy J.A. Janssen Source Type: research
More News: Chronic Obstructive Pulmonary | Clinical Trials | Morphine | Palliative | Respiratory Medicine